Hai-Ping Dai (Haiping Dai)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 20

Top Topics

Acute Myeloid Leukemia

Newly Diagnosed

Ulcerative Colitis

Stem Cell Transplantation

Top Venues

Blood cancer journal

Annals of hematology

British journal of haematology

American journal of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Yan-Yan Li, Shuai-Shuai Ge, Yuan-Hong Huang, Ming-Zhu Xu, Chao-Ling Wan, Kai-Wen Tan, Tao Tao, Hai-Xia Zhou, Sheng-Li Xue, Hai-Ping Dai
Efficacy and safety of cladribine, low-dose cytarabine and venetoclax in relapsed/refractory acute myeloid leukemia: results of a pilot study. Blood cancer journal 14 (1) (2024)
Yan-Yan Li, Shuai-Shuai Ge, Yuan-Hong Huang, Ming-Zhu Xu, Chao-Ling Wan, Kai-Wen Tan, Tao Tao, Hai-Xia Zhou, Sheng-Li Xue, Hai-Ping Dai
Efficacy and safety of cladribine, low-dose cytarabine and venetoclax in relapsed/refractory acute myeloid leukemia: results of a pilot study. Blood cancer journal 14 (1) (2024)
Cheryl A C Peretz, Vanessa E Kennedy, Anushka Walia, Cyrille L Delley, Andrew Koh, Elaine Tran, Iain C Clark, Corey E Hayford, Chris D'Amato, Yi Xue, Kristina M Fontanez, Aaron A May-Zhang, Trinity Smithers, Yigal Agam, Qian Wang, Hai-Ping Dai, Ritu Roy, Aaron C Logan, Alexander E Perl, Adam R Abate, Adam Olshen, Catherine C Smith
Multiomic single cell sequencing identifies stemlike nature of mixed phenotype acute leukemia. Nature communications 15 (1) (2024)
Han-Yu Cao, Hui-Ying Li, Wen-Zhi Cai, Yuan-Hong Huang, Qiao-Cheng Qiu, Zheng- Li, Yang Xu, Sheng-Li Xue, Hai-Ping Dai
Genetic and clinical characteristics of acute B-cell lymphoblastic leukemia with MEF2D fusions and report of two novel MEF2D rearrangements. Annals of hematology (2024)
Yan-Yan Li, Shuai-Shuai Ge, Yuan-Hong Huang, Ming-Zhu Xu, Chao-Ling Wan, Kai-Wen Tan, Tao Tao, Hai-Xia Zhou, Sheng-Li Xue, Hai-Ping Dai
Efficacy and safety of cladribine, low-dose cytarabine and venetoclax in relapsed/refractory acute myeloid leukemia: results of a pilot study. Blood cancer journal 14 (1) (2024)
Li-Li Han, Xia Yang, Hai-Ping Dai, Junfeng Zhu
A Case of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia with Coexistence of the JAK2V617F Clone Turkish journal of haematology : official journal of Turkish Society of Haematology 41 (2) (2024)
Chao-Ling Wan, Yu-Qing Liu, Fang-Tong Liu, Yuan-Hong Huang, Han-Yu Cao, Si-Man Huang, Kai-Wen Tan, Shuai-Shuai Ge, Miao Wang, Mei-Jing Liu, Zi-Hao Wang, Zheng Li, Sheng-Li Xue, Hai-Ping Dai
Venetoclax with hypomethylating agents versus intensive chemotherapy in newly diagnosed acute myeloid leukemia with myelodysplasia related changes: A propensity score-matched analysis based on International Consensus Classification. Blood cancer journal 14 (1) (2024)
Chao-Ling Wan, Yu-Qing Liu, Fang-Tong Liu, Yuan-Hong Huang, Han-Yu Cao, Si-Man Huang, Kai-Wen Tan, Shuai-Shuai Ge, Miao Wang, Mei-Jing Liu, Zi-Hao Wang, Zheng Li, Sheng-Li Xue, Hai-Ping Dai
Venetoclax with hypomethylating agents versus intensive chemotherapy in newly diagnosed acute myeloid leukemia with myelodysplasia related changes: A propensity score-matched analysis based on International Consensus Classification. Blood cancer journal 14 (1) (2024)
Yan-Yan Li, Shuai-Shuai Ge, Yuan-Hong Huang, Ming-Zhu Xu, Chao-Ling Wan, Kai-Wen Tan, Tao Tao, Hai-Xia Zhou, Sheng-Li Xue, Hai-Ping Dai
Efficacy and safety of cladribine, low-dose cytarabine and venetoclax in relapsed/refractory acute myeloid leukemia: results of a pilot study. Blood cancer journal 14 (1) (2024)
Miao Wang, Han-Yu Cao, Kai-Wen Tan, Qiao-Cheng Qiu, Yuan-Hong Huang, Shuai-Shuai Ge, Zi-Hao Wang, Jia Chen, Xiao-Wen Tang, De-Pei Wu, Sheng-Li Xue, Zheng Li, Hai-Ping Dai
Venetoclax plus hypomethylating agents in newly diagnosed acute myeloid leukemia patients with RUNX1::RUNX1T1: a retrospective propensity score matching study. Blood cancer journal 13 (1) (2023)
Yuan-Hong Huang, Chao-Ling Wan, Hai-Ping Dai, Sheng-Li Xue
Targeted therapy and immunotherapy for T cell acute lymphoblastic leukemia/lymphoma. Annals of hematology (2023)
Kai-Wen Tan, Yi-Yan Zhu, Qiao-Cheng Qiu, Man Wang, Hong-Jie Shen, Si-Man Huang, Han-Yu Cao, Chao-Ling Wan, Yan-Yan Li, Hai-Ping Dai, Sheng-Li Xue
Rapid molecular response to dasatinib in Ph-like acute lymphoblastic leukemia patients with ABL1 rearrangements: case series and literature review. Annals of hematology (2023)
Shuai-Shuai Ge, Qiao-Cheng Qiu, Hai-Ping Dai, Xiang-Dong Shen, Tian-Mei Wu, Jia-Hui Du, Chao-Ling Wan, Hong-Jie Shen, De-Pei Wu, Sheng-Li Xue, Song-Bai Liu
Mutation spectrum of FLT3 and significance of non-canonical FLT3 mutations in haematological malignancy. British journal of haematology (2023)
Li Huo, Zhibo Zhang, Haixia Zhou, Jundan Xie, Airui Jiang, Qian Wang, Zixuan Ding, Hai-Ping Dai, Dandan Liu, Ni Wu, Qiaocheng Qiu, Liang Ma, Man Wang, Wenjuan Wang, Sheng-Li Xue, Zixing Chen, De-Pei Wu, Hong Yao, Suning Chen, Hongjie Shen
Causative germline variant p.Y259C of DDX41 recurrently identified in acute lymphoblastic leukaemia. British journal of haematology (2023)
Wei Cui, Xin-Yue Zhang, Zheng Li, Hai-Ping Dai, Jia Yin, Qing-Ya Cui, Si-Ning Liu, Li-Qing Kang, Lei Yu, De-Pei Wu, Xiao-Wen Tang
Long-term follow-up of tandem CD19/CD22 CAR T-Cells in r/r B-ALL patients with high-risk features. American journal of hematology (2023)
Qian Wang, Wen-Zhi Cai, Qin-Rong Wang, Ming-Qing Zhu, Ling-Zhi Yan, Yan Yu, Xie-Bing Bao, Hong-Jie Shen, Hong Yao, Jun-Dan Xie, Tong-Tong Zhang, Ling Zhang, Xiao-Yu Xu, Zhe Shan, Hong Liu, Jian-Nong Cen, Dan-Dan Liu, Jin-Lan Pan, Da-Ru Lu, Jia Chen, Yang Xu, Ri Zhang, Ying Wang, Sheng-Li Xue, Miao Miao, Yue Han, Xiao-Wen Tang, Hui-Ying Qiu, Ai-Ning Sun, Jin-Yan Huang, Hai-Ping Dai, De-Pei Wu, Su-Ning Chen
Integrative genomic and transcriptomic profiling reveals distinct molecular subsets in adult mixed phenotype acute leukemia. American journal of hematology (2022)
Hai-Ping Dai, Wei Cui, Qing-Ya Cui, Wen-Juan Zhu, Hui-Min Meng, Min-Qing Zhu, Xia-Ming Zhu, Lin Yang, De-Pei Wu, Xiao-Wen Tang
Haploidentical CD7 CAR T-cells induced remission in a patient with TP53 mutated relapsed and refractory early T-cell precursor lymphoblastic leukemia/lymphoma. Biomarker research 10 (1) (2022)
Xin-Yue Zhang, Hai-Ping Dai, Ling Zhang, Si-Ning Liu, Yin Dai, De-Pei Wu, Xiao-Wen Tang
MRD-Negative Remission Induced in EP300-ZNF384 Positive B-ALL Patients by Tandem CD19/CD22 CAR T-Cell Therapy Bridging to Allogeneic Stem Cell Transplantation. OncoTargets and therapy 14 (2021)
Danqing Kong, Changju Qu, Hai-Ping Dai, Zheng Li, Jia Yin, Suning Chen, Liqing Kang, Guanghua Chen, Mingqing Zhu, Lei Yu, Depei Wu, Xiaowen Tang
CAR-T therapy bridging to allogeneic HSCT provides durable molecular remission of Ph+ mixed phenotype acute leukaemia with minimal residual disease. British journal of haematology 191 (2) (2020)
Chao Ding, Su-Ning Chen, Roderick A F Macleod, Hans G Drexler, Stefan Nagel, De-Pei Wu, Ai-Ning Sun, Hai-Ping Dai
MiR-130a is aberrantly overexpressed in adult acute myeloid leukemia with t(8;21) and its suppression induces AML cell death. Upsala journal of medical sciences 123 (1) (2018)